<code id='34B1AE5345'></code><style id='34B1AE5345'></style>
    • <acronym id='34B1AE5345'></acronym>
      <center id='34B1AE5345'><center id='34B1AE5345'><tfoot id='34B1AE5345'></tfoot></center><abbr id='34B1AE5345'><dir id='34B1AE5345'><tfoot id='34B1AE5345'></tfoot><noframes id='34B1AE5345'>

    • <optgroup id='34B1AE5345'><strike id='34B1AE5345'><sup id='34B1AE5345'></sup></strike><code id='34B1AE5345'></code></optgroup>
        1. <b id='34B1AE5345'><label id='34B1AE5345'><select id='34B1AE5345'><dt id='34B1AE5345'><span id='34B1AE5345'></span></dt></select></label></b><u id='34B1AE5345'></u>
          <i id='34B1AE5345'><strike id='34B1AE5345'><tt id='34B1AE5345'><pre id='34B1AE5345'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:entertainment    Page View:2
          Judge's gavel
          Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

          WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

          Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

          advertisement

          Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Surge in Apellis stock fueled by confidence in safety of its eye drug
          Surge in Apellis stock fueled by confidence in safety of its eye drug

          MollyFerguson/STATSharesofApellisPharmaceuticalsarerebounding,drivenbyagrowingbeliefamongsomeinvesto

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          FDA approves updated Covid vaccines

          ASafewaypharmacistadministersaPfizerCovid-19boosteratavaccinationclinicinOctober2021inSanRafael,Cali